GLP-1 Receptor Agonists: A Promising but Underexplored Treatment for Glaucoma, Diabetic Retinopathy, and Eye Diseases
Leading ophthalmologists and metabolic researchers are investigating whether GLP-1 receptor agonists—drugs currently approved for type 2 diabetes and obesity—could become a breakthrough treatment for glaucoma, age-related macular degeneration (AMD), and ... Read More